Xenetic Biosciences Cash Position $14.9M
Xenetic Biosciences (NASDAQ:XBIO) will report on Q2 2022.
GreenLight Biosciences Announces Private Placement Of ~$109M
BOSTON, Aug. 12, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences (NASDAQ:GRNA), a public benefit corporation striving to bring effective and safe solutions to make food clean and affordable for everyone and
Inseego Announces MiFi X PRO 5G UW Hotspot Now Available At Verizon
Inseego Corp. (NASDAQ:INSG), a leader in 5G and intelligent IoT device-to-cloud solutions, today introduced the new MiFi® X PRO 5G UW mobile hotspot, delivering the full range of 5G connectivity including
Sidus Space Q2 EPS $(0.15) Down From $(0.05) YoY, Sales $1.85M
Sidus Space (NASDAQ: SIDU) reported quarterly losses of $(0.15) per share. This is a 200 percent decrease over losses of $(0.05) per share from the same period last year. The company reported $1.85 million in sales this quarter.
Applied Therapeutics Q2 EPS $(0.96) Up From $(0.99) YoY
Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(0.96) per share. This is a 3.03 percent increase over losses of $(0.99) per share from the same period last year.
CASI Pharmaceuticals Q2 EPS $(0.56) Beats $(0.64) Estimate, Sales $8.57M Beat $7.87M Estimate
CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.64) by 12.5 percent. This is a 40 percent decrease over losses of $(0.40) per share from
Superior Drilling Q2 Sales $4.54M Beat $4.13M Estimate
Superior Drilling (AMEX:SDPI) reported quarterly sales of $4.54 million which beat the analyst consensus estimate of $4.13 million by 9.95 percent. This is a 33.60 percent increase over sales of $3.40 million the same
Unity Biotechnology Q2 EPS $(0.19) Up From $(0.32) YoY
Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.19) per share. This is a 40.63 percent increase over losses of $(0.32) per share from the same period last year.
Rapid Micro Biosystems Announces Review Of Strategic Alternatives; Says Rejects Unsolicited, Non-Binding $5/Share Proposal From Kennedy Lewis Investment Management
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast,
Honest Co Q2 EPS $(0.11) Misses $(0.08) Estimate, Sales $78.49M Beat $76.27M Estimate
Honest Co (NASDAQ:HNST) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.08) by 37.5 percent. This is a 52.17 percent increase over losses of $(0.23) per share from the